Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Gasparini Insider Profile
4 Followers
Robert Gasparini, CSO at NeoGenomics, holds 2.88M shares in HealthLynked (Ticker: HLYK), holds 8.44K shares in NeoGenomics (Ticker: NEO).
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-32.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Robert Gasparini
Robert Gasparini's Trading History
NeoGenomics
May 27, 2014
CSO
Informative Buy
25.00K
$133.08K
HealthLynked
Oct 06, 2023
Director
Uninformative Buy
―
$80.65K
List of latest transactions for each holding click on a transaction to see Robert Gasparini's performance on stock
You May Also Like
Robert Gasparini insider profile FAQ
What is the percentage of profitable transactions made by Robert Gasparini?
The percentage of profitable transactions made by Robert Gasparini is 0%.
What is the average return per transaction made by Robert Gasparini?
The average return per transaction made by Robert Gasparini is -32.50%.
What stocks does Robert Gasparini hold?
Robert Gasparini holds: NEO, HLYK stocks.
What was Robert Gasparini’s latest transaction?
Robert Gasparini latest transaction was an Uninformative Buy of ―.
What was Robert Gasparini's most profitable transaction?
Robert Gasparini’s most profitable transaction was an Informative Buy of NEO stock on May 27, 2014. The return on the trade was 0.00%.
What is Robert Gasparini's role in NeoGenomics?
Robert Gasparini's role in NeoGenomics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.